The company in question is, GW Pharmaceuticals plc (NASDAQ:GWPH) currently with a stock price of 128.15 (-0.30% today). The market cap for GW Pharmaceuticals plc is 3313.5, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for GW Pharmaceuticals plc is 141.13. Currently GW Pharmaceuticals plc is trading with a P/E of *TBA, and a forward P/E of *TBA. Average volume for GW Pharmaceuticals plc is 621.35 and so far today it is 130388.
Performance in the last year for GW Pharmaceuticals plc has been 48.97%. For EPS growth, GW Pharmaceuticals plc has seen a growth of -159.60%, and is looking to grow in the next year to -28.80%. More long term stats show that EPS growth has been -48.70% over the last five years and could be *TBA for the next five years. GW Pharmaceuticals plc has seen sales growth quarter over quarter at -73.30%, with EPS growth quarter over quarter at 45.60%. The 20-day simple moving average is 24.53%, with the 200-day simple moving average coming to 58.50%.
Since the IPO date for GW Pharmaceuticals plc on the 05/01/2013, GW Pharmaceuticals plc has seen performance year to date to be 85.10%. With GW Pharmaceuticals plc trading at 128.15, the dividend yield is *TBA, and the EPS is -3.41.
So could GW Pharmaceuticals plc, be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 184.08 and the P/B is at 10.86. The P/cash is 13.74, with P/free cash flow at *TBA.
GW Pharmaceuticals plc ability to deal with debt shows that the current ratio is 6.1, and the quick ratio is 6. This is with long term debt/equity at 0.02, and total debt/equity at 0.02.
In terms of margins, GW Pharmaceuticals plc has a gross margin of 81.60%, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for GW Pharmaceuticals plc is *TBA. Return on assets come to -21.50% with return on investment coming to -18.10%.
Insider ownership for GW Pharmaceuticals plc, is at *TBA and institutional ownership comes to 61.60%. Outstanding shares are at 25.78. While shares float is 22.22. The float short is currently 11.50%, and short ratio is 4.11.